Evidence map›Paper›PMID 29507774›Full record

ReviewNPJ Regenerative medicine2018

Comparative regenerative mechanisms across different mammalian tissues.

Siiri E Iismaa, Xenia Kaidonis, Amy M Nicks, Nikolay Bogush, Kazu Kikuchi, Nawazish Naqvi, Richard P Harvey, Ahsan Husain, Robert M Graham

Abstract readReview
In one paragraph

Review in NPJ Regenerative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Multifunctional VEGF/CeOPharmaceutics · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Aging: the wound that never starts healing.Nature communications · 2025
    Review

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Siiri E Iismaa1Victor Chang Cardiac Research Institute, Sydney, NSW 2010 Australia.
Xenia Kaidonis1Victor Chang Cardiac Research Institute, Sydney, NSW 2010 Australia.
Amy M Nicks1Victor Chang Cardiac Research Institute, Sydney, NSW 2010 Australia.
Nikolay Bogush3Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA 30322 USA.
Kazu Kikuchi1Victor Chang Cardiac Research Institute, Sydney, NSW 2010 Australia.
Nawazish Naqvi3Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA 30322 USA.
Richard P Harvey1Victor Chang Cardiac Research Institute, Sydney, NSW 2010 Australia.
Ahsan Husain3Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA 30322 USA.
Robert M Graham1Victor Chang Cardiac Research Institute, Sydney, NSW 2010 Australia.ORCID 0000-0002-1042-2587

Funding

Development of the Postnatal HeartR01HL127726 · NHLBI · EMORY UNIVERSITY · PI HUSAIN, AHSAN, NAQVI, NAWAZISH ALI · 2016 to 2019
$1.6M
NHLBI NIH HHS R01 HL127726
6 · The paper itself

Abstract

Stimulating regeneration of complex tissues and organs after injury to effect complete structural and functional repair, is an attractive therapeutic option that would revolutionize clinical medicine. Compared to many metazoan phyla that show extraordinary regenerative capacity, which in some instances persists throughout life, regeneration in mammalians, particularly humans, is limited or absent. Here we consider recent insights in the elucidation of molecular mechanisms of regeneration that have come from studies of tissue homeostasis and injury repair in mammalian tissues that span the spectrum from little or no self-renewal, to those showing active cell turnover throughout life. These studies highlight the diversity of factors that constrain regeneration, including immune responses, extracellular matrix composition, age, injury type, physiological adaptation, and angiogenic and neurogenic capacity. Despite these constraints, much progress has been made in elucidating key molecular mechanisms that may provide therapeutic targets for the development of future regenerative therapies, as well as previously unidentified developmental paradigms and windows-of-opportunity for improved regenerative repair.

Identifiers

PMID29507774
PMCPMC5824955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.